Network-based pharmacology and experimental validation to explore the mechanism of action of the Jiawei Pentongling formula for the treatment of endometriosis-related pain
This study utilized network pharmacology and animal models to demonstrate that the Jiawei Pentongling formula alleviates endometriosis-related pain by downregulating the PI3K/Akt signaling pathway and reducing inflammatory factors.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (34)
- Activated AKT Pathway Promotes Establishment of Endometriosis via openalex
- Apigenin induces ROS‐dependent apoptosis and ER stress in human endometriosis cells via openalex
- Apigenin inhibits tumor necrosis factor α–induced cell proliferation and prostaglandin E2 synthesis by inactivating NFκB in endometriotic stromal cells via openalex
- Effects of inhibiting the PI3K/Akt/mTOR signaling pathway on the pain of sciatic endometriosis in a rat model via openalex
- Endometriosis via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Genome-Wide DNA Methylation Analysis Predicts an Epigenetic Switch for GATA Factor Expression in Endometriosis via openalex
- Inflammatory Mediators and Pain in Endometriosis: A Systematic Review via openalex
- Innervation of ectopic endometrium in a rat model of endometriosis via openalex
- Pathogenesis and pathophysiology of endometriosis via openalex
- PI3K/AKT pathway is altered in the endometriosis patient’s endometrium and presents differences according to severity stage via openalex
- Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial via openalex
- W2296095373 via openalex
- W2402258526 via openalex
- W2596152408 via openalex
- W2804636211 via openalex
- W2806412664 via openalex
- W2944128385 via openalex
- W3045561650 via openalex
- W3197658746 via openalex
- W3198422808 via openalex
- W3216817814 via openalex
- W2276901773 via openalex
- W2029335735 via openalex
- W2060541890 via openalex
- W2078278102 via openalex
- W2083752025 via openalex
- W2110254651 via openalex
- W2120532705 via openalex
- W2124679671 via openalex
- W2172201406 via openalex
- W2234985919 via openalex
- W1159773778 via openalex
- W2294409638 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-06-21T06:12:49.409960+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pmc
- last seen: 2026-05-13T20:22:03.195721+00:00
- pubmed
- last seen: 2026-06-21T06:10:27.119083+00:00